Ethnopharmacological Insights Into Pausinystalia Genus: Botany, Phytochemistry, and Pharmacological Potential.
Abstract
The Pausinystalia genus (Rubiaceae) comprises woody plants mainly distributed in tropical Africa and has a long history of traditional medicinal use, particularly as aphrodisiacs and for treating fatigue, fever, leprosy, and respiratory infections. At least 52 compounds have been identified or reported from the genus, including 37 indole alkaloids, phenolic compounds, flavonoids, and fatty acids. These constituents and derived extracts or fractions exhibit diverse biological activities, including effects on sexual function, antimicrobial, antioxidant, hypoglycemic, anti-inflammatory, analgesic, cardioprotective, insecticidal, and cytotoxic activities. However, evidence remains uneven across species and pharmacological endpoints, with research focusing largely on Pausinystalia yohimbe, Pausinystalia macroceras, and their alkaloid constituents. Variations in plant materials, extraction procedures, chemical composition, doses, models, and outcome measures limit cross-study comparisons and extrapolation. This review critically synthesizes the botanical characteristics, ethnomedicinal uses, phytochemistry, pharmacological properties, and toxicological profiles of Pausinystalia, emphasizing evidence quality, species differences, methodological limitations, and research gaps. Future research priorities, including chemical standardization, pharmacokinetic and biotransformation studies, mechanistic validation, safety evaluation, quality control, clinical investigation, and sustainable utilization, are discussed to support the reproducible, evidence-based, and clinically relevant development of Pausinystalia-derived preparations.